An under-$10 stock in the biotechnology and drugs complex that looks ready to trigger a breakout trade is Inovio Pharmaceuticals (INO), which is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. This stock is off to a strong start in 2012, with shares up sharply by 48%.
If you take a look at the chart for Inovio Pharmaceuticals, you'll notice that this stock has been uptrending very strong for the past six months, with shares soaring from 38 cents to a recent high of 76 cents per share. During that uptrend, shares of INO have been mostly making higher lows and higher highs, which is bullish technical price action. That trend has now pushed shares of INO within range of triggering a major breakout trade.Traders should now look for long-biased trades in INO once it manages to break out above some near-term overhead resistance at 76 cents per share with high volume. Look for a sustained move or close above 76 cents with volume that hits near or above its three-month average volume of 553,362 shares. If that breakout triggers soon, then INO will setup to re-test or possibly take out its next major overhead resistance levels at 89 to 96 cents per share, and possibly even $1.20 to $1.30 a share or higher. Traders can look to buy INO as long as it's trending above its 50-day moving average of 60 cents per share with strong upside volume flows. I would add to any long positions once INO manages to take out 76 cents per share with heavy volume, and then add again above 89 to 96 cents per share.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV